EUVIMEDEUVIMED entdecken
CrossrefInfokarte

MARCH5 Links Hypoxia to Neutrophil Ferroptosis in SLE via FSP1 Ubiquitination

Jing Zhang, Fulin Cai, Jiansen Lu, Zhiwei Liu

Immunity, Inflammation and Disease · 2026-11 · 14 (11)

DOI: 10.1002/iid3.70583 ↗
AbstractBibliografische Angaben

Abstract

ABSTRACT Purpose Ferroptosis plays an important role in the progression of systemic lupus erythematosus (SLE). This study aims to investigate the molecular mechanism by which membrane‐associated RING‐CH‐type finger protein 5 (MARCH5) regulates ferroptosis suppressor protein 1 (FSP1), a key regulator of ferroptosis resistance, under hypoxic conditions and its impact on SLE progression. Methods We established a Toll‐like receptor 7/8 (TLR7/8) agonist‐induced mouse model of SLE under normoxic or hypoxic conditions and longitudinally evaluated pathological manifestations and survival. In vitro, the effects of hypoxia on ferroptosis induced by glutathione peroxidase 4 (GPX4) inhibitors or FSP1 inhibitors were assessed using the Cell Counting Kit‐8 (CCK‐8) assay. Cycloheximide (CHX) chase assays and pharmacological inhibitors of protein degradation pathways were employed to investigate how hypoxia regulates FSP1 stability. Candidate E3 ligases involved in FSP1 ubiquitination were identified using bioinformatic prediction tools and validated through March5 knockdown or overexpression experiments. Finally, neutrophil‐specific March5 knockout mice were generated to further demonstrate that hypoxia promotes SLE progression through a MARCH5‐dependent mechanism. Results Chronic hypoxia significantly exacerbates SLE pathology by selectively disrupting FSP1‐dependent, rather than GPX4‐dependent, ferroptosis resistance in neutrophils. Mechanistically, hypoxia does not affect Aifm2 (i.e., the gene encoding FSP1) mRNA expression but accelerates FSP1 protein degradation through MARCH5‐mediated ubiquitination and proteasomal turnover. Hypoxia enhances the interaction between MARCH5 and FSP1, promoting FSP1 destabilization. Knockdown of MARCH5 prevents hypoxia‐induced FSP1 degradation and neutrophil ferroptosis, whereas neutrophil‐specific March5 deletion improves survival, reduces autoantibody production, restores complement levels, and alleviates organ damage in SLE mice. Conclusions This study reveals a pathogenic axis whereby hypoxia compromises neutrophil ferroptosis resistance and exacerbates SLE progression through MARCH5‐mediated ubiquitination and degradation of FSP1. These findings elucidate how impaired FSP1‐dependent ferroptosis defense contributes to chronic inflammatory disease progression and identify the MARCH5–FSP1 interaction as a potential therapeutic target for SLE and other ferroptosis‐associated autoimmune disorders.

Wissen, das zu Ihrer Arbeit passt.

Vom kostenlosen Einstieg über die persönliche Recherche bis zur vollständigen Research Suite.

Tarife ansehen →

Sind alle Verlagsvolltexte enthalten?

Nein. Bibliografische Nachweise, Abstracts und Volltexte sind unterschiedliche Inhalte. Ob ein Volltext verfügbar ist, hängt von der Quelle, Open Access und Ihren vorhandenen Lizenzen ab. Ein EUVIMED-Tarif ersetzt keine zusätzlichen Verlagsrechte.

Tarife ansehen →